Senior insider sale
President and CEO at DENALI THERAPEUTICS INC. — senior position signals high conviction
$580.8K
35.20K shares
What this filing means
WATTS RYAN J. plans to sell 35.20K shares of DENALI THERAPEUTICS INC. valued at approximately $580.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/6/2026ACC: 0001724310-26-000003
DirectorOfficer· President and CEO
Since Aug 2018
35.20K
Shares to sell
$580.8K
Approx. market value
35.20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Lapse - See Remarks
Equity Compensation
1/3/2026
35.20KTotal acquired35.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2026 | Restricted Stock Lapse - See Remarks Equity Compensation | 35.20K | — |
| Total | 35.20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
35.20K
Market value
$580.8K
1/6/2026
Total
Units
35.20K
Value
$580.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/6/2026 | 35.20K | $580.8K | NASDAQ | Planned |
| Total | 35.20K | $580.8K | ||